EW
EW
Market ClosedEdwards Lifesciences Corporation
US
16.00K employees
CEO: Bernard J. Zovighian
Founded: 2000
$107.15
+$0.00(+NaN%)
Market Cap
61.61B
Beta
0.83
52W Range
N/A
Dividend Yield
0.00%
EW Price Chart
Historical price performance
Loading MCI price data...
MarketCI Investment Signals
AI-synthesized investment signal for EW built from valuation, fundamentals, sentiment, and risk models
Investment Signal
BuyPass %
71.43%
Score
5/7
Fair Value Estimate
Cash flow analysis • Multiple methods
$54.90
AI Price Target
Machine learning • Price prediction
$105.59
Market Sentiment
News & social media analysis
0.05
Value Investor Price
Classic value analysis
$16.24
Financial Health
Bankruptcy risk assessment
12.00
Quality Score
Financial strength rating
6.00
AI Investment Grade
Deep analysis of filings & news
78.00
Key Investment Highlights
Important factors affecting EW investment thesis
Due Diligence Analysis
Investment criteria assessment and scoring
Overall Assessment
67.57% Good
Conditions Met
25.00/37.00
Due Diligence Score
67.57%Due Diligence Conditions
Investment analysis conditions and results
Fail | |
Fail | |
Fail | |
Fail | |
Fail | |
Pass |
Showing 1 to 6 of 46 conditions
Latest News
Recent news and updates for EW
No recent news available for EW
Core Financials
Loading financial data for EW...
Explore EW
EW in the Healthcare
Large Cap